S&P 500 may face selling pressure as systematic funds reach full exposure
Steven J. Hamerslag, a director at CorVel Corp (NASDAQ:CRVL), a $6 billion healthcare management services company, has sold 10,000 shares of the company’s common stock. According to InvestingPro data, the stock has delivered an impressive 42% return over the past year and currently trades near its 52-week high of $128.61. The transaction, which took place on February 6, 2025, saw shares sold at a price of $123.4787 each, amounting to a total value of approximately $1.23 million. Following this sale, Hamerslag holds 314,000 shares in the company. The shares were sold indirectly through the Hamerslag Trust, where Hamerslag serves as the trustee. InvestingPro analysis indicates that CorVel is currently trading above its Fair Value, with a high P/E ratio relative to near-term earnings growth being one of several key metrics available to subscribers. For comprehensive insider trading analysis and access to 8 additional ProTips, consider exploring CorVel’s detailed Pro Research Report.
In other recent news, CorVel Corporation has reported impressive results for Q4 of 2024. The company’s earnings per share (EPS) saw a significant increase of 39%, reaching $0.46, and revenues also rose by 13%, hitting $228 million. This robust performance is attributed to CorVel’s continued focus on technological innovation, including AI and automation in healthcare services. In addition, the company completed a 3-for-1 stock split in December 2024.
CorVel’s EPS of $0.46 and revenue of $228 million exceeded market expectations, contributing to a positive response from the market. The company’s commitment to expanding its AI and automation capabilities is expected to continue, with projections for EPS and revenue growth for FY2025 and FY2026 set at $1.76, $1.82, $854.96 million, and $884.88 million, respectively.
Despite potential challenges such as medical inflation and increased competition in AI-driven healthcare services, CorVel remains focused on technological advancements and efficient operations. These recent developments underscore the company’s strategic initiatives and strong financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.